{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:47:49Z","timestamp":1787161669192,"version":"build-2736575974"},"reference-count":61,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pregnancy-associated venous thromboembolism (VTE) is a leading cause of maternal mortality, but is relatively uncommon. It is clear that the antepartum and postpartum periods have different magnitudes of risk and distinct risk factors for VTE and therefore must be considered separately. Absolute daily risks of VTE must be understood and explored when deciding to prescribe antepartum or postpartum thromboprophylaxis and must also be balanced against the downsides of prophylaxis. When the risks for VTE and bleeding are both low, other burdens of thromboprophylaxis must be weighed in and a decision made after an individualized patient values- and patient preferences\u2013based discussion. Risk stratification is essential to ensure that the practicing clinician strikes the right balance.<\/jats:p>","DOI":"10.1182\/asheducation-2014.1.387","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T13:39:03Z","timestamp":1416836343000},"page":"387-392","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":75,"title":["Pregnancy and venous thromboembolism: \u2018TIPPS\u2019 for risk stratification"],"prefix":"10.1182","volume":"2014","author":[{"given":"Marc","family":"Rodger","sequence":"first","affiliation":[{"name":"Ottawa Blood Disease Centre, Ottawa Hospital,"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, and"},{"name":"Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111703395765500_B1","first-page":"56","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"BJOG"},{"issue":"6","key":"2019111703395765500_B2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/AOG.0b013e3181fdfb11","article-title":"Pregnancy-related mortality in the United States, 1998 to 2005","volume":"116","author":"Berg","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2019111703395765500_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.2010.02847.x","article-title":"Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008: the Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"2019111703395765500_B4","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","author":"Rodger","journal-title":"Lancet"},{"issue":"2","key":"2019111703395765500_B5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","article-title":"An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy","volume":"104","author":"Macklon","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"2019111703395765500_B6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"2019111703395765500_B7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019111703395765500_B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1160\/TH07-05-0359","article-title":"Calibrated automated thrombin generation in normal uncomplicated pregnancy","volume":"99","author":"Rosenkranz","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111703395765500_B9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","article-title":"APC resistance and other haemostatic variables during pregnancy and puerperium","volume":"81","author":"Kjellberg","year":"1999","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019111703395765500_B10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2004.01108.x","article-title":"D-dimer levels during delivery and the postpartum","volume":"3","author":"Epiney","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111703395765500_B11","first-page":"CD001689","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","volume":"2","author":"Bain","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2019111703395765500_B12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111703395765500_B13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-153-9-201011020-00280","article-title":"Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial","volume":"153","author":"CLOTS Trial Collaboration","year":"2010","journal-title":"Ann Intern Med"},{"issue":"9679","key":"2019111703395765500_B14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(09)60941-7","article-title":"Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial","volume":"373","author":"Dennis","year":"2009","journal-title":"Lancet"},{"issue":"9891","key":"2019111703395765500_B15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(13)61050-8","article-title":"Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial","volume":"382","author":"Dennis","year":"2013","journal-title":"Lancet"},{"key":"2019111703395765500_B16","volume-title":"Pradax Product Monograph: Dabigatran Etixilate Capsules","author":"Boehringer Ingelheim Canada","year":"2009"},{"key":"2019111703395765500_B17","volume-title":"Xarelto Product Monograph, Rivaroxaban Tablet","author":"Bayer","year":"2008"},{"key":"2019111703395765500_B18","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"8","key":"2019111703395765500_B19","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"2019111703395765500_B20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","article-title":"Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin","volume":"168","author":"Dahlman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"2019111703395765500_B21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1538-7836.2007.02634.x","article-title":"Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial","volume":"5","author":"Rodger","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111703395765500_B22","first-page":"1237","article-title":"Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women","volume":"98","author":"Bauersachs","year":"2007","journal-title":"Thromb Haemost"},{"issue":"11","key":"2019111703395765500_B23","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"2019111703395765500_B24","article-title":"Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial","author":"Rodger","journal-title":"Lancet"},{"issue":"17","key":"2019111703395765500_B25","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"issue":"21","key":"2019111703395765500_B26","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN: the Scottish Pregnancy Intervention Study: a multicentre randomised controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111703395765500_B27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000010216","article-title":"Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin","volume":"49","author":"Huhle","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"2019111703395765500_B28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-12-3","article-title":"Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis","volume":"12","author":"Lazo-Langner","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"2019111703395765500_B29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1538-7836.2008.02961.x","article-title":"Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study","volume":"6","author":"Jacobsen","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111703395765500_B30","first-page":"800","article-title":"Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia","volume":"86","author":"Martinelli","year":"2001","journal-title":"Thromb Haemost"},{"issue":"11","key":"2019111703395765500_B31","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2010.04038.x","article-title":"Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms","volume":"8","author":"Jacobsen","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111703395765500_B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111703395765500_B33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH13-01-0077","article-title":"How I treat heterozygous hereditary antithrombin deficiency in pregnancy","volume":"110","author":"Bramham","year":"2013","journal-title":"Thromb Haemost"},{"issue":"20","key":"2019111703395765500_B34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism: recurrence of clot in this pregnancy study group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111703395765500_B35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","article-title":"Activated protein C resistance (FV:Q506) and pregnancy","volume":"81","author":"Lindqvist","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111703395765500_B36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3181c88918","article-title":"Prothrombin gene G20210A mutation and obstetric complications","volume":"115","author":"Silver","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2019111703395765500_B37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/AOG.0b013e3181c68907","article-title":"Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women","volume":"115","author":"Said","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2019111703395765500_B38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0037-1612659","article-title":"The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance","volume":"85","author":"Clark","year":"2001","journal-title":"Thromb Haemost"},{"key":"2019111703395765500_B39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"2019111703395765500_B40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"issue":"4","key":"2019111703395765500_B41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111703395765500_B42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09513599309152499","article-title":"Heterogeneity of human prolactin levels in serum during the early postpartum period","volume":"7","author":"Kamel","year":"1993","journal-title":"Gynecol Endocrinol"},{"key":"2019111703395765500_B43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111703395765500_B44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111703395765500_B45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"2019111703395765500_B46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1067\/mob.2001.107919","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study","volume":"184","author":"Danilenko-Dixon","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"2019111703395765500_B47","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood-2012-11-469551","article-title":"Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom","volume":"121","author":"Sultan","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111703395765500_B48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1538-7836.2011.04186.x","article-title":"Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?","volume":"9","author":"Roeters van Lennep","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111703395765500_B49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111703395765500_B50","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: the pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thromb Haemost"},{"issue":"4","key":"2019111703395765500_B51","first-page":"771","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial","volume":"104","author":"Gris","year":"2010","journal-title":"Thromb Haemost"},{"issue":"14","key":"2019111703395765500_B52","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2011-11-391383","article-title":"Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial","volume":"119","author":"Martinelli","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111703395765500_B53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","volume":"7","author":"Rey","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111703395765500_B54","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2019111703395765500_B55","first-page":"835","article-title":"A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"BJOG"},{"issue":"12","key":"2019111703395765500_B56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"Br J Obstet Gynaecol"},{"key":"2019111703395765500_B57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(89)90095-1","article-title":"Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis?","volume":"160","author":"Tengborn","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111703395765500_B58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"De Stefano","year":"2006","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111703395765500_B59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1471-0528.1985.tb01082.x","article-title":"Prophylaxis of thromboembolism in pregnancy: an alternative","volume":"92","author":"Lao","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"2019111703395765500_B60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0412.2011.01098.x","article-title":"Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism","volume":"90","author":"Lindqvist","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"2019111703395765500_B61","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1998.tb10212.x","article-title":"Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin","volume":"105","author":"Gibson","year":"1998","journal-title":"Br J Obstet Gynaecol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/387\/1249655\/bep00114000387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/387\/1249655\/bep00114000387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:56:09Z","timestamp":1598489769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2014\/1\/387\/20398\/Pregnancy-and-venous-thromboembolism-TIPPS-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2014.1.387","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}